Innoviva, Inc., Director, 10% Owner at Armata Pharmaceuticals, Inc. (ARMP), bought 8,571,870 shares at $3.25 ($27.9M) on 2021-03-17, disclosed to the SEC on 2021-03-17.
Open-market purchase of $27.9M ARMP by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.25 | 4,285,935 | $13.9M | 50.0% |
| 2 | $3.25 | 4,285,935 | $13.9M | 50.0% |
| Total | $3.25 avg | 8,571,870 | $27.9M | 100% |
| Filing → |
| ETTX | BUY | 2020-09-01 | $25.0M | — | Filing → |
| ETTX | BUY | 2020-06-12 | $31.7M | — | Filing → |
| ARMP | BUY | 2020-03-31 | $44.3M | — | Filing → |